Fig. 2From: A real-world study of treatment patterns following disease progression in epithelial ovarian cancer patients undergoing poly-ADP-ribose polymerase inhibitor maintenance therapyKaplan-Meier estimates of TTSP in PS patients who received one line of subsequent chemotherapy before PARPi maintenance therapy based on BRCA statusBack to article page